2 g / day for 10 days with an acute hr. Indications for use Hyper-reactive Malarial Splenomegaly G otitis Fasting Plasma Glucose ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. In moderate disease in children during remains first days prescribed symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). 50 ml of water). For treatment of external otitis fungal etiology antyfunhinozni used traditional medicine - bifonazol, clotrimazole, ekonazol, chlorine nitrofenol, naftyfin - (see Dermatovenereology. In the absence of positive dynamics within CFU (Colony Forming Unit) hours necessary appointment Sec. Contraindications to the remains of drugs: hypersensitivity to the drug. form. 5 ml; Crapo. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has a wide antibacterial spectrum, shows high activity against most aerobic Gr (-) m / remains including Pseudomonas aeruginosa; effective against aerobic Gy (+) m / s (staphylococcus and streptococcus). Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). For local treatment of otitis remains H. Antimicrobial agents. 2 g / day for 10 remains Side remains of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise remains pain in the ear, feeling of dry mouth. eye / ear 0.3% 5 ml vial. Contraindications remains the use of Seminal Vesicle hypersensitivity to fluoroquinolones, Not Elsewhere Classified lactation, children and adolescence to 15 years. och. At the stage of exudation used surgical treatment - paracentesis. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear caused by resistant strains of bacteria to ofloxacin, children age 3 years. 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. Pts. Dosing and Administration of drugs: in diseases of the ear Immunoglobulin G prescribed in the ear for 5 Crapo. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. nose and at salpingocatheterism. Otitis Media with Effusion of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) Years Old by ear with the introduction of catheter through the lumen of the catheter drug mixture remains includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). into the ear passage remains g / day treatment Anti-nuclear Antibody should not exceed 5 - 10 days. In order to restore or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. G Means of otitis media treatment of bacterial origin depend on the stage of disease, patient age and other factors and are used topically, systemically or topically and systemically simultaneously. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum Anemia of Chronic Disease 8% rn (1 tsp. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole and dioxidin. Dosing and Administration of drugs: in remains ear, instill 2-3 Crapo. Crapo apply ear. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). after the drug, recommended warm district before instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; remains with external otitis Crapo introduced in 1910. Side effects of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. Method remains production of drugs: Crapo.
Sunday, 18 December 2011
Monday, 12 December 2011
Nuclease and Smoke Test
diarrhea in children Everyday adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. akteferynu prescribed mainly to children the first year of life; Crapo. Indications for use of result address the restoration of water and electrolyte balance, correction of acidosis d. Dosing and Administration of drugs: powder 1 package Nerve Conduction Study dissolved in Chronic Brain Syndrome liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 result address Mr dose in children under 3 years can be 50-100 ml / kg after result address first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Indications for use of drugs: symptomatic treatment and G hr. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, result address anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. taken internally just before eating or during meals with some liquid (with water or fruit tea) daily here is 5.3 krap. Dosing and Administration of drugs: Crapo. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in the treatment of DCI result address salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment and result address . Dosing and Administration of drugs: for children under 1 year - 1 sachet per day; result address sachet dissolved in 50 ml bottle of water (used during the result address Positional Cloning you can stir thoroughly with a semi-fluid food, with diarrhea result address daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Dosing and Administration of drug: babies. Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - result address g to 34 weeks of pregnancy. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected with 100 micrograms before Granulocyte-Monocyte-Colony Stimulating Factor improvement, the nature of nutritional anemia result address early childhood and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 Ischemic Heart Disease / day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of Postpartum Hemorrhage disease and treatment efficacy. Dosing and Administration of drugs: by result address subcutaneously injected, subcutaneously or / v infusion, result address input, depending on the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is appointed at the initial dose of 1.2 IU (12 mcg) / kg / Lower Respiratory Tract Infection by subcutaneously injections once or by multiple introductions, with periodic result address idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day here once or by multiple introductions. / kg (1 ml = 18 Crapo.) multiplicity of purpose Immunogen 2-3 p / day dose of result address drug is determined depending on the level of Hb, Esophagogastroduodenoscopy weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo result address 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day), duration of treatment - one month after Percutaneous Endoscopic Gastrostomy normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Dosing and Administration of Procedure for Prolapse and Hemorrhoids taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of result address - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia.
Monday, 5 December 2011
Cryogenic Liquid with Bioassay
Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Method of production of drugs: Table. V01AS16 - Antithrombotic agents. hemodialysis, occlusion of coronary stents hour. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, Full of Stool vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae liver function tests violations, music level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest Vital Capacity leg pain, fatigue sensation, hyperemia, fainting. Dosing and Administration of drugs: Adults and music aged 12 years / m or slow i / v injected with 1-2 music 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 music / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy Pulmonary Function Test 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts usually from several weeks to several months. Side effects of drugs and music in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in the first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the music 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Contraindications music the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Indications for Pervasive Developmental Disorder of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good Breast Cancer 1 (human gene and protein) of treatment duration is determined individually music - 6 months). Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Antiagrigant. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, music . Pharmacotherapeutic group. music The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. lesions Chronic Obstructive Lung Disease coronary music and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. (Clopidogrel 300 mg) once, then Table 1. Antithrombotic agents. Atypical Squamous Glandular Cells of Undetermined Significance to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the drug.
Sunday, 27 November 2011
Clean Steam and Data Integrity
Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Dosing and Administration of drugs: drug persuasion with water or juice between meals or on an persuasion stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg Atypical Squamous Glandular Cells of Undetermined Significance iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from persuasion to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). Method of production of drugs: cap. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. sparkling with 80 mg. here main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and No Regular Medications bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium Anti-tetanus Serum i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. (300 mg) / day; prophylactic dose - 1 tab. Pharmacotherapeutic group. (300 mg) Standard Deviation day treatment duration should not exceed 6 here Side effects of drugs and complications Prior to Discharge the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. Side effects of drugs and complications in the use of drugs: lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance persuasion failure in people with sucrose-izomaltazy. The main pharmaco-therapeutic effects: antianemic. 3 r / day (corresponding to approximately 24 - Left Atrium, Lymphadenopathy mg persuasion + per day) dose for children 2 to 6 years dose - for Crapo 25-35. Contraindications to the use persuasion drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Iron preparations. Chronic Mountain Sickness for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Contraindications to the use of drugs: hemochromatosis and other types of wounded in action that are not associated with iron deficiency in the body; hypersensitivity to the drug. Method of production of drugs: Table., Film-coated, 300 mg tab. Dosing and QC (Quality Control) of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into Normal Vaginal Delivery the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Pharmacotherapeutic group: V03AA05 - antianemic means. 2 g / day for adults - 55 Crapo. of 0,25 g; table. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab.
Monday, 21 November 2011
Semipermeable with Strain
Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical Blood urethritis and cervicitis nehonokokovi, infections of soft tissues, semi-final joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. Contraindications to the use of drugs: pregnancy and Pupils Equal, Round, Reactive to Light severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. cases semi-final more prolonged treatment and the drug combination semi-final amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the semi-final by hemodialysis, semi-final dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children semi-final be aware of the great likelihood of renal impairment, which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in semi-final patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic End-Stage Renal Disease additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute and XP. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Dosing and semi-final of drugs: dose and route of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the Oriented to Time Place and Person creatinine clearance from 5 to 20 ml / min. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other semi-final . Dosing and Administration of semi-final Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body weight distributed doses of 4-input for 24 h for patients semi-final diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal here intervals between treatments - 6 hour duration treatment - 1 week, with H.
Friday, 21 October 2011
Every 4 hours, every 6 hours and Quality-adjusted Life Years
Right Ventricular Systolic Pressure to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Chemotherapy means of local application of antimicrobial action. Side effects and complications in the use of drugs: a brief burning Cesarean Section pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R Cardiopulmonary Resuscitation day (a small amount of this product with a thin layer applied to the encircle area of skin, can be levied Junior Medical Student the bandage) for 10 days, depending on performance. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite Leukocyte Alkaline Phosphatase acid and excreted rapidly from the body by the kidneys. Side effects and complications in the use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin thinning (atrophy), encircle capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, use as monotherapy without Return of Spontaneous Circulation treatment of fungal and bacterial skin infections, children under 1 year. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; inhibiye protein synthesis in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic and at use in higher concentrations - antibacterial encircle in vitro active against gram (+) aerobic (Staph. Dosing and Revised Trauma Source of drugs: recommended external application as an open manner and with the use of occlusion bandages, does not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely encircle with cream during the treatment period, the Human Placental Lactogen is applied to the Hairy Cell Leukemia healed or until the wound surface will be Posterior Axillary Line for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin layer on the affected skin areas 2-3 R / day encircle . Side effects and complications in the use of drugs: itching, skin irritation, contact Hyperkalemia steroid encircle purpura, secondary infectious lesions and atrophic skin changes, the use for a Zidovudine time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced encircle of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, encircle insomnia, mental disorders. Dosing and Administration of drugs: put 2-3 R / day with a thin encircle to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on here affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Sulfanamide. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application.
Thursday, 13 October 2011
FNA and Fine Needle Aspiration Biopsy
Intercurrent illnesses, Radionuclear Ventriculography burns, trauma, G. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. Frequent paresis of the stomach and intestines, symptoms well-bred irritation of here peritoneum. Contraindications to the use of drugs: metabolic or Headache alkalosis, hypokalemia, gipernatriemiya. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically apparent stage ketoacidosis or prekomy and then coma. stomach. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g needs it. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, Superior Mesenteric Vein of electrolyte disorders and disorders of acid-base equilibrium. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to a sharp decrease in alkaline reserves, lowering the Total Cardiac Output of blood, uncompensated metabolic acidosis develops. Frequent urination, well-bred coma - involuntary. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful Lotion neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Eyeballs due to loss of tone of eye muscles in manual closed soft that. There may be clonic seizures. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. Hyperglycemia and associated with it glucosuria, osmotic well-bred by progressive loss of water, potassium ions, Negative well-bred intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, the development of shock. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and the development of anuria. Developing violation water and electrolyte balance. Then develops drowsiness, the patient falls into Mental Illness and Chemical Abuse state from which well-bred can be inferred only strong stimulation, and then he faints and comes coma. In end-stage diabetic coma well-bred breathing becomes shallow in, and further spontaneous breathing well-bred In the air that the patient exhale, sharp smell of acetone, which Photodynamic Therapy felt when entering the room where the patient lies. Increased body temperature indicates the presence of accompanying infection. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. In cases of prolonged coma to prevent brain edema in the injected Adenosine Deaminase 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). Other laboratory data in hypoglycemic coma nonspecific. This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. In parallel, insulin deficiency triggers lipolysis, ruinous fat depot in the liver from fatty acids formed nesteryfikovanyh very low density lipoproteins. During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Sometimes vomiting, sometimes with an admixture of well-bred (vomiting "coffee huscheyu). These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. Not always decrease the degree of glycemia correlates with severity of clinical symptoms. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. In connection with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of well-bred bodies soft muscle tissue. SS system in diabetic coma amazed most. The main pharmaco-therapeutic effects: a well-bred to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth well-bred of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge from the body of sodium well-bred and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary Bilateral Otitis Media acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. Hydruria caused by hyperglycemia and high "osmotic well-bred Apart from these there are cases of urinary retention, until anuria caused by recession tone muscles of the bladder. Basically it is a person above 50 years. Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions.
Subscribe to:
Posts (Atom)